Sei Investments Co. Sells 56,902 Shares of Tenet Healthcare Corporation $THC

Key Points

• Sei Investments Co. cut its Tenet Healthcare position by 16.7% in the first quarter, selling 56,902 shares and leaving it with 283,520 shares worth about $53.5 million.
• Tenet posted a strong second quarter, with $6.12 EPS and $6.04 billion in revenue, both well above analyst expectations. Revenue rose 6.8% year over year.
• Management raised FY 2026 EPS guidance to $20.30-$21.69, and analysts remain broadly positive, with a consensus rating of Moderate Buy and a price target of $246.47.

Sei Investments Co. decreased its position in Tenet Healthcare Corporation (NYSE:THC - Free Report) by 16.7% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 283,520 shares of the company's stock after selling 56,902 shares during the quarter. Sei Investments Co. owned 0.33% of Tenet Healthcare worth $53,502,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. Triumph Capital Management bought a new stake in shares of Tenet Healthcare during the 3rd quarter valued at about $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare during the 4th quarter valued at about $26,000. Elyxium Wealth LLC purchased a new position in shares of Tenet Healthcare during the 4th quarter worth $29,000. Canada Pension Plan Investment Board purchased a new position in Tenet Healthcare during the second quarter valued at $35,000. Finally, Meeder Asset Management Inc. grew its stake in shares of Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company's stock valued at $38,000 after acquiring an additional 114 shares during the period. Hedge funds and other institutional investors own 95.44% of the company's stock.

Key Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet beat Q2 expectations by a wide margin, reporting $6.12 EPS versus estimates around $4.26, while revenue of $6.04 billion also came in above forecasts. The company cited strong same-store revenue growth and effective expense management. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Management raised FY 2026 EPS guidance to $20.30-$21.69, well above prior Street expectations, signaling that the earnings beat may not be a one-quarter event. Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
• Positive Sentiment: Investor enthusiasm was further supported by commentary highlighting hospital growth, expense control, and M&A momentum, with multiple reports describing the quarter as a “blockbuster” and noting the stock’s strong response. Tenet's Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade
• Neutral Sentiment: Tenet’s earnings call transcript and presentation may provide more detail on the quarter and outlook, but the main stock driver today appears to be the earnings beat and guidance increase rather than any new strategic surprise. Tenet Healthcare Corporation (THC) Q2 2026 Earnings Call Transcript
• Neutral Sentiment: Media coverage also noted broader strength in hospital stocks, which may be adding to the move in Tenet Healthcare (THC). Why Tenet Healthcare Stock Is Soaring Today

Analyst Upgrades and Downgrades

THC has been the topic of a number of research analyst reports. Morgan Stanley set a $254.00 price target on Tenet Healthcare in a report on Friday, May 1st. UBS Group reaffirmed a "buy" rating on shares of Tenet Healthcare in a research note on Friday. Wells Fargo & Company boosted their price target on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an "overweight" rating in a research note on Monday, July 13th. Robert W. Baird decreased their target price on Tenet Healthcare from $245.00 to $210.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 5th. Finally, TD Cowen reduced their price objective on Tenet Healthcare from $242.00 to $233.00 and set a "buy" rating on the stock in a research note on Monday, June 22nd. Seventeen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $246.47.

Tenet Healthcare Stock Performance

THC stock opened at $233.10 on Friday. The firm has a 50-day simple moving average of $185.16 and a two-hundred day simple moving average of $197.62. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. Tenet Healthcare Corporation has a one year low of $146.60 and a one year high of $247.21. The firm has a market cap of $20.08 billion, a price-to-earnings ratio of 8.99, a PEG ratio of 1.93 and a beta of 1.27.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a return on equity of 27.17% and a net margin of 10.27%.The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same period in the previous year, the business earned $4.02 EPS. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. On average, equities analysts forecast that Tenet Healthcare Corporation will post 21 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the transaction, the director directly owned 24,805 shares of the company's stock, valued at $4,399,166.75. The trade was a 10.79% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the transaction, the director directly owned 16,804 shares of the company's stock, valued at $2,932,634.08. The trade was a 25.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.97% of the stock is owned by corporate insiders.

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.